Karakus Savas, Kiran Gurkan, Ciralik Harun
Sivas State Hospital Obstetrics and Gynecology Clinic, Sivas, Turkey.
Aust N Z J Obstet Gynaecol. 2009 Dec;49(6):685-8. doi: 10.1111/j.1479-828X.2009.01093.x.
The vaginal route is more effective than the other drug delivery routes for some specific indications.
To compare the efficacy of a vaginal progesterone preparation with that of oral dydrogesterone.
A total of 69 women with irregular dysfunctional uterine bleeding were randomly assigned into one of two groups: oral dydrogesterone group (n = 35) and vaginal progesterone group (n = 34). At the end of a three-month treatment period, the women were re-evaluated. The endometrial histology findings and menstrual cycle characteristics were used as primary outcome measures. Pearson chi-square and Fisher's exact test were used for data analysis.
Findings from 54 eligible women were evaluated. There was no statistically significant difference in both menstrual recordings and endometrial histology results between the groups.
Vaginal micronised progesterone could be an alternative to oral preparations in the treatment of dysfunctional uterine bleeding. This needs to be further evaluated in adequately controlled randomised trials against other effective treatments.
对于某些特定适应症,阴道给药途径比其他药物递送途径更有效。
比较阴道用黄体酮制剂与口服地屈孕酮的疗效。
总共69例功能失调性子宫出血的女性被随机分为两组之一:口服地屈孕酮组(n = 35)和阴道用黄体酮组(n = 34)。在三个月的治疗期结束时,对这些女性进行重新评估。子宫内膜组织学检查结果和月经周期特征用作主要结局指标。采用Pearson卡方检验和Fisher精确检验进行数据分析。
对54例符合条件的女性的结果进行了评估。两组之间在月经记录和子宫内膜组织学结果方面均无统计学上的显著差异。
阴道用微粉化黄体酮在治疗功能失调性子宫出血方面可以替代口服制剂。这需要在针对其他有效治疗方法的充分对照随机试验中进一步评估。